Corrigendum to “Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341–350]
The authors regret that the numbers of bone metastasis in this LEO trial (Table 1) need to be corrected as follows:
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Jae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Su-Jin Koh, Jaekyung Cheon, Joohyuk Sohn, Gun Min Kim, Keun Seok Lee, Sung Hoon Sim, In Hae Park, Sung-Bae Kim Tags: Corrigendum Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hormones | Ovarian Cancer | Ovaries | Women